Ranger Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-143,280
| Closed | -$1.58M | – | 150 |
|
|
2017
Q2 | $1.58M | Hold |
143,280
| – | – | 0.11% | 70 |
|
|
2017
Q1 | $1.4M | Buy |
143,280
+27,590
| +24% | +$270K | 0.1% | 71 |
|
|
2016
Q4 | $1.25M | Buy |
115,690
+7,500
| +7% | +$81K | 0.09% | 93 |
|
|
2016
Q3 | $1.11M | Buy |
108,190
+8,290
| +8% | +$85K | 0.08% | 99 |
|
|
2016
Q2 | $1.31M | Sell |
99,900
-26,580
| -21% | -$347K | 0.08% | 84 |
|
|
2016
Q1 | $1.39M | Buy |
126,480
+4,100
| +3% | +$45.1K | 0.09% | 86 |
|
|
2015
Q4 | $1.13M | Sell |
122,380
-8,460
| -6% | -$77.8K | 0.07% | 88 |
|
|
2015
Q3 | $908K | Buy |
130,840
+9,950
| +8% | +$69.1K | 0.05% | 94 |
|
|
2015
Q2 | $1.19M | Buy |
120,890
+1,350
| +1% | +$13.3K | 0.06% | 97 |
|
|
2015
Q1 | $1.06M | Buy |
119,540
+23,050
| +24% | +$204K | 0.05% | 93 |
|
|
2014
Q4 | $845K | Sell |
96,490
-1,390
| -1% | -$12.2K | 0.04% | 92 |
|
|
2014
Q3 | $674K | Buy |
+97,880
| New | +$674K | 0.04% | 93 |
|